A Study of SPY001-001 in Healthy Volunteers

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 6, 2024

Primary Completion Date

May 5, 2026

Study Completion Date

May 5, 2026

Conditions

Healthy

Interventions

DRUG

SPY001-001

Experimental

OTHER

Placebo

Trial Locations (2)

Spyre Site 2, Cypress

Spyre Site 1, Montreal

All Listed Sponsors

collaborator

Altasciences Company Inc.

INDUSTRY

lead

Spyre Therapeutics, Inc.

INDUSTRY

NCT06448247 - A Study of SPY001-001 in Healthy Volunteers | Biotech Hunter | Biotech Hunter